AM7499 is a non-selective cannabinoid receptor agonist . It has been designed to be readily hydrolysed by plasma esterases and to be less prone to deposition in bodily fat than existing classical cannabinoid agonists. AM7499 exhibits remarkably high in vitro and in vivo potency with shorter duration of action than the currently existing classical cannabinoid agonists.
